Clinical Trial Details

EORTC-04891

Back to Clinical Trials Database

Essais cliniques phase II d'une nouvelle nitrosourée: la Cystémustine dans les poumons, les adénocarcinomes colo-rectaux, les gliomes, les mélanomes, les reins, les sarcomes des parties molles et les tumeurs de la tête et du cou.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 15-Jan-1990
Date Step1 close: 02-Jan-1996
Data management at EORTC Yes
Design Phase 2
Randomized open
Targeted Sample size EORTC Groups: 150
Treatment
Study Staff
Type of cancer
Participating groups
Participating centers
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number